公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2016 | Anaplastic Lymphoma Kinase (ALK) Kinase Domain Mutation Following ALK Inhibitor(s) Failure in Advanced ALK Positive Non–Small-Cell Lung Cancer: Analysis and Literature Review | YEN-TING LIN ; CHONG-JEN YU ; CHIH-HSIN YANG ; JIN-YUAN SHIH | Clinical Lung Cancer | 26 | 23 | |
2019 | Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations | YEN-TING LIN ; JIN-SHING CHEN ; WEI-YU LIAO ; CHAO-CHI HO ; CHIA-LIN HSU ; Yang C.-Y.; KUAN-YU CHEN ; JIH-HSIANG LEE ; ZHONG-ZHE LIN ; JIN-YUAN SHIH ; CHIH-HSIN YANG ; CHONG-JEN YU | International Journal of Cancer | 53 | 46 | |
2020 | Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer | YEN-TING LIN ; TZU-HSIU TSAI ; SHANG-GIN WU ; Liu Y.-N.; CHONG-JEN YU ; JIN-YUAN SHIH | Lung Cancer | 17 | 17 | |
2022 | Cone-Beam Computed Tomography-Derived Augmented Fluoroscopy Improves the Diagnostic Yield of Endobronchial Ultrasound-Guided Transbronchial Biopsy for Peripheral Pulmonary Lesions | CHING-KAI LIN ; Fan, Hung-Jen; ZONG-HAN YAO ; YEN-TING LIN ; Wen, Yueh-Feng; SHANG-GIN WU ; CHAO-CHI HO | Diagnostics (Basel, Switzerland) | 5 | 2 | |
2014 | Development of renal cysts after crizotinib treatment in advanced ALK-positive non-small-cell lung cancer | YEN-TING LIN ; YU-FEN WANG ; CHIH-HSIN YANG ; CHONG-JEN YU ; SHANG-GIN WU ; JIN-YUAN SHIH ; PAN-CHYR YANG | Journal of Thoracic Oncology | 49 | 38 | |
2020 | Diagnosis of mediastinal tuberculous lymphadenitis using endobronchial ultrasound-guided transbronchial needle aspiration with rinse fluid polymerase chain reaction | CHING-KAI LIN ; LI-TA KENG ; Lim C.-K.; YEN-TING LIN ; SHU-YUNG LIN ; Chen L.-Y.; ZONG-HAN YAO ; YUNG-HSUAN CHEN ; CHAO-CHI HO | Journal of the Formosan Medical Association | 9 | 9 | |
2023 | Effects of Early Short-Course Corticosteroids on Immune-Related Adverse Events in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors | DE-RUI HUANG ; BIN-CHI LIAO ; Hsu, Wei-Hsun; CHING-YAO YANG ; YEN-TING LIN ; SHANG-GIN WU ; TZU-HSIU TSAI ; KUAN-YU CHEN ; CHAO-CHI HO ; WEI-YU LIAO ; JIN-YUAN SHIH ; CHONG-JEN YU ; CHIH-HSIN YANG ; ANN-LII CHENG ; YING-CHUN SHEN | Oncology | | | |
2017 | Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-sensitive Exon 19 Insertion and Exon 20 Insertion in Patients With Advanced Non–Small-cell Lung Cancer | YEN-TING LIN ; Liu Y.-N.; SHANG-GIN WU ; CHIH-HSIN YANG ; JIN-YUAN SHIH | Clinical Lung Cancer | 32 | 26 | |
2019 | The Impact of Clinical Factors, ALK Fusion Variants, and BIM Polymorphism on Crizotinib-Treated Advanced EML4–ALK Rearranged Non-small Cell Lung Cancer | YEN-TING LIN ; Liu Y.-N.; JIN-YUAN SHIH | Frontiers in Oncology | 10 | 8 | |
2020 | An International Real-World Analysis of the Efficacy and Safety of Lorlatinib Through Early or Expanded Access Programs in Patients With Tyrosine Kinase Inhibitor–Refractory ALK-Positive or ROS1-Positive NSCLC | Zhu, Viola W; YEN-TING LIN ; Kim, Dong-Wan; Loong, Herbert H; Nagasaka, Misako; To, Hao; Ang, Yvonne Li-En; Ock, Chan-Young; Tchekmedyian, Nishan; Ou, Sai-Hong Ignatius; Syn, Nicholas L; Reungwetwattana, Thanyanan; CHIA-CHI LIN ; Soo, Ross A | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 45 | 36 | |
2023 | LncRNA SLCO4A1-AS1 suppresses lung cancer progression by sequestering the TOX4-NTSR1 signaling axis | Chen, Yi-Ling; Liu, Yi-Nan; YEN-TING LIN ; Tsai, Meng-Feng; SHANG-GIN WU ; Chang, Tzu-Hua; CHIA-LANG HSU ; HUEY-DONG WU ; JIN-YUAN SHIH | Journal of biomedical science | 2 | 0 | |
2020 | MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process | Wang, Hsin-Yi; Liu, Yi-Nan; SHANG-GIN WU ; HSU, CHIA-LANG ; Chang, Tzu-Hua; Tsai, Meng-Feng; YEN-TING LIN ; JIN-YUAN SHIH | Cancer biomarkers : section A of Disease markers | 25 | 20 | |
2020 | Not All EGFR Exon 20 Insertions Are Created Equal | YEN-TING LIN ; JIN-YUAN SHIH | JTO clinical and research reports | 2 | 0 | |
2018 | Outcome of untreated lung nodules with histological but no microbiological evidence of tuberculosis | Chung C.-L.; YEN-FU CHEN ; YEN-TING LIN ; JANN-YUAN WANG ; SHUENN-WEN KUO ; JIN-SHING CHEN | BMC Infectious Diseases | 5 | 4 | |
2022 | Programmed Cell Death Protein-1/Programmed Death-Ligand 1 Inhibitors in NSCLC: Two Heads Are Better Than One | YEN-TING LIN ; JIN-YUAN SHIH | Journal of Thoracic Oncology | 0 | 0 | |
2021 | The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study | Huang, Yen-Hsiang; Hung, Jen-Yu; Ko, How-Wen; Su, Po-Lan; Lai, Chun-Liang; Chang, Huang-Chih; Hsia, Te-Chun; Lin, Sheng-Hao; Wu, Kuan-Li; Yang, Cheng-Ta; Su, Wu-Chou; Chu, Yi-Chun; Wang, Chin-Chou; WEI-YU LIAO ; YEN-TING LIN ; Lin, Ching-Hsiung; Lin, Meng-Chih; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Lee, Mei-Hsuan; SUNG-LIANG YU ; CHAO-CHI HO ; Chang, Gee-Chen | Therapeutic advances in medical oncology | 3 | 2 | |
2021 | Resistance profiles of anaplastic lymphoma kinase tyrosine kinase inhibitors in advanced non–small-cell lung cancer: a multicenter study using targeted next-generation sequencing | YEN-TING LIN ; Chiang, Chi-Lu; Hung, Jen-Yu; Lee, Mei-Hsuan; Su, Wu-Chou; Wu, Shang-Yin; Wei, Yu-Feng; Lee, Kang-Yun; Tseng, Yen-Han; Su, Jian; Chung, Hsin-Pei; Lin, Chih-Bin; Ku, Wen-Hui; Chiang, Tsai-Shin; Chiu, Chao-Hua; JIN-YUAN SHIH | European Journal of Cancer | 26 | 21 | |
2023 | Response to Letter to the Editor: "Factors Other Than Low-Dose Computed Tomography Screening Related to Stage Shift and Improved Survival of Lung Cancer" | CHING-YAO YANG ; YEN-TING LIN ; Lin, Li-Ju; PAN-CHYR YANG | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 0 | 0 | |
2022 | Risk of thromboembolism in non-small-cell lung cancers patients with different oncogenic drivers, including ROS1, ALK, and EGFR mutations | Wang, H-Y; SHANG-GIN WU ; YEN-TING LIN ; CHUNG-YU CHEN ; JIN-YUAN SHIH | ESMO open | 3 | 3 | |
2023 | Stage Shift Improves Lung Cancer Survival: Real-World Evidence | CHING-YAO YANG ; YEN-TING LIN ; Lin, Li Ju; Chang, Ya Hsuan; Chen, Hsuan Yu; Wang, Yi Pin; JIN-YUAN SHIH ; CHONG-JEN YU ; PAN-CHYR YANG | Journal of Thoracic Oncology | 9 | 8 | |